Drs I.J.H. Vriens
Recent publications
-
Lammers, S. W. M., Geurts, S. M. E., Hermans, K. E. P. E., Kooreman, L. F. S., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., Honkoop, A. H., van den Berkmortel, F. W. P. J., de Roos, W. K., Linn, S. C., Imholz, A. L. T., Vriens, I. J. H., & Tjan-Heijnen, V. C. G. (2025). The prognostic and predictive value of the luminal-like subtype in hormone receptor-positive breast cancer: an analysis of the DATA trial. ESMO Open, 10(2), Article 104154. https://doi.org/10.1016/j.esmoop.2025.104154More information about this publication
-
ter Welle-Butalid, M. E., Derhaag, J. G., van Bree, B. E., Vriens, I. J. H., Goddijn, M., Balkenende, E. M. E., Beerendonk, C. C. M., Bos, A. M. E., Homminga, I., Benneheij, S. H., van Os, H. C., Smeenk, J. M. J., Verhoeven, M. O., van Bavel, C. C. A. W., Tjan-Heijnen, V. C. G., & van Golde, R. J. T. (2024). Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study. Human Reproduction, 39(12), 2693-2701. Article deae243. https://doi.org/10.1093/humrep/deae243More information about this publication
-
Lammers, S. W. M., Geurts, S. M. E., Hermans, K. E. P. E., van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., Honkoop, A. H., van den Berkmortel, F. W. P. J., de Roos, W. K., Imholz, A. L. T., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2024). Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial. Breast Cancer Research and Treatment, 208(1), 179-192. https://doi.org/10.1007/s10549-024-07411-wMore information about this publication
-
Heesterbeek, C. J., Tjan-Heijnen, V. C. G., Heimovaara, J. H., Lenaerts, L., Lok, C., Vriens, I. J. H., Van Opstal, D., Boon, E. M. J., Sie, D., de Die-Smulders, C. E. M., Amant, F., Macville, M. V. E., & Dutch NIPT Consortium (2024). Prenatal cell-free DNA testing of women with pregnancy-associated cancer: a retrospective cross-sectional study. The Lancet Regional Health – Europe, 45, Article 101024. https://doi.org/10.1016/j.lanepe.2024.101024More information about this publication
-
Lammers, S. W. M., Meegdes, M., Vriens, I. J. H., Voogd, A. C., de Munck, L., van Nijnatten, T. J. A., Keymeulen, K. B. M. I., Tjan-Heijnen, V. C. G., & Geurts, S. M. E. (2024). Treatment and survival of patients diagnosed with high-risk HR+/HER2- breast cancer in the Netherlands: a population-based retrospective cohort study. ESMO Open, 9(5), Article 103008. https://doi.org/10.1016/j.esmoop.2024.103008More information about this publication
-
Heimovaara, J. H., van Calsteren, K., Lok, C. A. R., Evens, A. M., Hoegl, J., Ferber, A., Fernandes, A., Vriens, I., van Zuylen, L., & Amant, F. (2024). Results of an international survey on the current organization of care for pregnant women with cancer. Acta Obstetricia et Gynecologica Scandinavica, 103(4), 751-756. https://doi.org/10.1111/aogs.14748More information about this publication
-
Welle-Butalid, M. E. T., van Osch, L., van Bree, B. E., Vriens, I. J. H., Derhaag, J. G., de Die-Smulders, C. E. M., Tjan-Heijnen, V. C. G., & van Golde, R. J. T. (2024). Considerations of breast cancer survivors to return for embryo transfer after fertility preservation: A qualitative study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 293, 27-31. https://doi.org/10.1016/j.ejogrb.2023.12.009More information about this publication
-
Lammers, S. W. M., Thurisch, H., Vriens, I. J. H., Meegdes, M., Engelen, S. M. E., Erdkamp, F. L. G., Dercksen, M. W., Vriens, B. E. P. J., Aaldering, K. N. A., Pepels, M. J. A. E., van de Winkel, L. M. H., Peters, N. A. J. B., Tol, J., Heijns, J. B., van de Wouw, A. J., Teeuwen, N. J. A., Geurts, S. M. E., & Tjan-Heijnen, V. C. G. (2024). The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry. Breast Cancer Research and Treatment, 203(2), 339-349. https://doi.org/10.1007/s10549-023-07108-6More information about this publication
-
Lammers, S. W. M., Geurts, S. M. E., Van Hellemond, I. E. G., Swinkels, A. C. P., Smorenburg, C. H., Van Der Sangen, M. J. C., Kroep, J. R., De Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., De Roos, W. K., Linn, S. C., Imholz, A. L. T., Smidt, M. L., Vriens, I. J. H., Tjan-Heijnen, V. C. G., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer. JNCI Cancer Spectrum, 7(6), Article pkad092. https://doi.org/10.1093/jncics/pkad092More information about this publication
-
Tjan-Heijnen, V. C. G., Lammers, S. W. M., Geurts, S. M. E., Vriens, I. J. H., Swinkels, A. C. P., Smorenburg, C. H., van der Sangen, M. J. C., Kroep, J. R., de Graaf, H., Honkoop, A. H., Erdkamp, F. L. G., de Roos, W. K., Linn, S. C., Imholz, A. L. T., & Dutch Breast Cancer Research Group (BOOG) for the DATA Investigators (2023). Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial. EClinicalMedicine, 58(1), Article 101901. https://doi.org/10.1016/j.eclinm.2023.101901More information about this publication